The TF FOXR2 promotes prostate cancer cell migration, proliferation, and invasion by increasing MMP-2 expression and activity, decreasing p27 expression and nuclear localization, and activating the β-catenin/cyclinD1/c-Myc pathway, as shown by FOXR2 knockdown experiments [39]. Here, FOXR2 is linked to prostate cancer.